As of 3:58pm ET
| +0.13 / +2.93%|
The 3 analysts offering 12-month price forecasts for Apollo Endosurgery Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +140.70% increase from the last price of 4.57.
The current consensus among 3 polled investment analysts is to Buy stock in Apollo Endosurgery Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.